Skip to main
IPX
IPX logo

IperionX Ltd (IPX) Stock Forecast & Price Target

IperionX Ltd (IPX) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

IperionX Ltd has demonstrated significant potential for growth, as evidenced by the upward adjustment of its 2029 EBITDA multiple from 7x to 8x, indicating ongoing progress in the company's operations. The anticipated ramp-up in production and revenue further supports a positive outlook for IperionX's valuation, suggesting that the company's financial performance is on an upward trajectory. Additionally, with the recent increase in the price target from $64 to $74 due to lower future dilution assumptions and a higher EBITDA multiple, the company's fundamentals appear robust and promising.

Bears say

IperionX Ltd faces significant risks associated with commodity price fluctuations, which can adversely affect its profitability and financial stability. The company is also exposed to operational challenges, including permitting or construction delays, production cost overruns, and the potential failure to capture market share. Additionally, unforeseen financial transactions or market events could further complicate IperionX's financial outlook, leading to negative implications for its stock performance.

IperionX Ltd (IPX) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IperionX Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IperionX Ltd (IPX) Forecast

Analysts have given IperionX Ltd (IPX) a Strong Buy based on their latest research and market trends.

According to 2 analysts, IperionX Ltd (IPX) has a Strong Buy consensus rating as of Dec 13, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $51, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $51, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IperionX Ltd (IPX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.